Reach Us +1-504-608-239
Editor - Junpeng | The Scripps Research Institute | 23384

Immunogenetics: Open Access
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Relevant Topics


Junpeng Qi
Research Associate
Department of Cancer Biology
The Scripps Research Institute
The Scripps Research Institute


Junpeng Qi received his Ph.D degree from Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences in 2012. He then joined Eli Lilly China Research and Development Center as a Research Scientist developing new drugs for Type II Diabetes. And now, he is a research associate focusing on antibody engineering for cancer therapy at The Scripps Research Institute, Florida.

Research Interest

Dr. Junpeng Qi is interested in Antibody Engineering and Cancer Immunotherapy


Narrations of Personality Disorders in a Famous Chinese Novel of the Eighteenth Century - A Dream of Red Mansions

Bispecific Antibodies: Bright Way for Cancer Therapeutics

Hongying Fan, Wanzhen Chen, Chanchan Shen, Yanhua Qin, Junpeng Zhu, You Xu, Qianqian Gao and Wei Wang
Research Article: J Psychiatry, 21: 440
DOI: 10.4172/2378-5756.1000440
Junpeng Qi
Editorial: J immuno Biol 1: e103
DOI: 10.4172/2476-1966.1000e103
Leave Your Message 24x7